Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Interaction Map description Network Comparison Type Rank Gene Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2175 to 2224 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein c21orf2 (c21orf-humf09g8.5) (yf5/a2). [source:swissprot;acc:o43822]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2874\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein c6orf55 (dopamine responsive protein drg-1) (my012 protein) (hspc228). [source:swissprot;acc:q9np79]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3219\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein cdc27hs (cell division cycle protein 27 homolog) (h-nuc). [source:swissprot;acc:p30260]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
860\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5210.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5749.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1034\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein cgi-126 (protein hspc155). [source:swissprot;acc:q9y3c8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
79\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3074.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4567.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.48558\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein cgi-140 (protein ptd008) (my006 protein). [source:swissprot;acc:q9y284]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3102\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein cgi-147. [source:swissprot;acc:q9y3e5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2529\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6436.43\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6283\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02442\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein cgi-27 (c21orf19-like protein). [source:swissprot;acc:q9y316]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2705\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4137.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4152.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00365\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein disulfide isomerase precursor (pdi) (ec 5.3.4.1) (prolyl 4- hydroxylase beta subunit) (cellular thyroid hormone binding protein) (p55). [source:swissprot;acc:p07237]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2104\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6916.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7295.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05481\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein fosb (g0/g1 switch regulatory protein 3). [source:swissprot;acc:p53539]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
86\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4942.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7037.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.42384\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein hspc134 (protein cda04). [source:swissprot;acc:q9by43]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
150\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11068\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8508.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.30082\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein kinase c and casein kinase substrate in neurons protein 1. [source:swissprot;acc:q9by11]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3020\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein kinase c and casein kinase substrate in neurons protein 2. [source:swissprot;acc:q9unf0]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3142\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein kinase c and casein kinase substrate in neurons protein 3 (sh3 domain-containing protein 6511) (endophilin i). [source:swissprot;acc:q9uks6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2845\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein kinase c binding protein 1 (rack7) (cutaneous t-cell lymphoma associated antigen se14-3) (ctcl tumor antigen se14-3) (zinc finger mynd domain containing protein 8). [source:swissprot;acc:q9ulu4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1850\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6158.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6551.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06387\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein kinase c, delta type (ec 2.7.1.-) (npkc-delta). [source:swissprot;acc:q05655]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2857\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein kinase c, epsilon type (ec 2.7.1.-) (npkc-epsilon). [source:swissprot;acc:q02156]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
960\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11773\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10733.2\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09688\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
protein kinase c, eta type (ec 2.7.1.-) (npkc-eta) (pkc-l). [source:swissprot;acc:p24723]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
965\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11773.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10733.8\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein kinase c, iota type (ec 2.7.1.37) (npkc-iota) (atypical protein kinase c-lamda/iota) (apkc-lambda/iota). [source:swissprot;acc:p41743]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
664\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6374.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7145.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12094\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein kinase c, theta type (ec 2.7.1.-) (npkc-theta). [source:swissprot;acc:q04759]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3186\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein kinase c, zeta type (ec 2.7.1.37) (npkc-zeta). [source:swissprot;acc:q05513]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
672\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6374.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7145.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12094\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein kinase clk2 (ec 2.7.1.-) (cdc-like kinase 2). [source:swissprot;acc:p49760]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1022\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6435.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7045.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09475\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein kinase clk3 (ec 2.7.1.-) (cdc-like kinase 3). [source:swissprot;acc:p49761]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1023\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6435.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7044.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09474\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein kinase nyd-sp25. [source:refseq;acc:nm\_033516]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2637\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6527.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6608.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01242\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein kinase pkx1 (ec 2.7.1.-). [source:swissprot;acc:p51817]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1711\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5917.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6322.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06853\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein kinase, interferon-inducible double stranded rna dependent activator; protein activator of the interferon-induced protein kinase. [source:refseq;acc:nm\_003690]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
24\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
950.561\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2108.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.21818\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 12a; myosin phosphatase, target subunit 1. [source:refseq;acc:nm\_002480]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1568\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5845.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6267.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07222\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 12b isoform a; myosin phosphatase regulatory subunit; myosin phosphatase, target subunit 2. [source:refseq;acc:nm\_002481]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1566\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5846.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6269.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0723\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 13b; apoptosis-stimulating protein of p53, 1. [source:refseq;acc:nm\_015316]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
490\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
15274.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13346.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14445\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14a; 17-kda pkc-potentiated inhibitory protein of pp1. [source:refseq;acc:nm\_033256]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
18\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
677.5\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
2.75351\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14c; serologically defined breast cancer antigen ny-br-81; pkc-potentiated pp1 inhibitory protein. [source:refseq;acc:nm\_030949]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
22\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 14d; pkc-dependent pp1 inhibitory protein. [source:refseq;acc:nm\_017726]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
20\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 7; sds22. [source:refseq;acc:nm\_002712]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
238\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
27642.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
22440.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.23182\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein phosphatase 2c beta isoform (ec 3.1.3.16) (pp2c-beta). [source:swissprot;acc:o75688]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
527\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4775.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5438.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13886\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein phosphatase inhibitor 2 (ipp-2). [source:swissprot;acc:p41236]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
313\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
21644.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
18098.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1959\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein regulator of cytokinesis 1; protein regulating cytokinesis 1. [source:refseq;acc:nm\_003981]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1887\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5438.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5783.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06335\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein sck (fragment). [source:swissprot;acc:p98077]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1827\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5633.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5997\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06454\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein tara (trio-associated repeat on actin) (hrihfb2122). [source:swissprot;acc:q9h2d6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2576\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5608.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5712.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01857\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein translation factor sui1 homolog (sui1iso1). [source:swissprot;acc:p41567]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2023\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3560.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3364.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05807\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein translation factor sui1 homolog gc20. [source:swissprot;acc:o60739]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1988\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3559.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3360.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05925\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec23a (sec23-related protein a). [source:swissprot;acc:q15436]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3135\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec23b (sec23-related protein b). [source:swissprot;acc:q15437]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3127\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec24a (sec24-related protein a) (fragment). [source:swissprot;acc:o95486]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3056\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec24b (sec24-related protein b). [source:swissprot;acc:o95487]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2956\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec24c (sec24-related protein c). [source:swissprot;acc:p53992]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2910\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec24d (sec24-related protein d). [source:swissprot;acc:o94855]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2903\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec61 alpha subunit isoform 1 (sec61 alpha- 1). [source:swissprot;acc:p38378]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2079\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3614.91\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3423.89\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05579\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec61 alpha subunit isoform 2 (sec61 alpha- 2). [source:swissprot;acc:q9y2r3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2078\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec61 gamma subunit. [source:swissprot;acc:p38384]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2265\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3612.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3453.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04606\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein x 0001. [source:refseq;acc:nm\_016302]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1582\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6376.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6833.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07175\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein x 0004. [source:refseq;acc:nm\_016301]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
16\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2671\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
871\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3.06659\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/